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ABSTRACT 
 
Background: RNTCP recommends examination of three sputum smears for diagnosis of TB. This may 
not be practicable under all conditions, especially in difficult areas. It further adds to the laboratory 
workload, cost of diagnosis and causes inconvenience to patients as well as for the health system.  
Objectives: The present study was undertaken to compare the efficiency of sputum examination in 
detecting the smear positive TB cases among the chest symptomatics with 2 sputum examinations Vs 
3 sputum examinations.  
Methods: A cross sectional study including sputum positive pulmonary tuberculosis patients from 2 
Tuberculosis Unit (5 Designated Microscopic Centre) of Municipal corporation of Vadodara.  
Results: The study conducted in the fourth quarter included 143 (23.1 percent) smear positive cases of 
TB. Dependence on the first specimen (spot) and third specimen (spot) could detect 88.1 percent and 
89.5 percent of the sputum positive patients’ respectively, while morning specimen could detect 97.3 
percent of the sputum positive patients. Comparison of 1st Vs 2nd and 2nd Vs 3rd showed a significant 
difference at P < 0.01. Repeat sputum Examination in only 11 patients out of 475 TB suspects 
identified 9% (1/11) smear positive cases.  
Conclusion: Two sputum smear examinations (one spot & one early morning specimen) are sufficient 
for diagnosis of tuberculosis Patients. 
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INTRODUCTION  
Tuberculosis (TB) remains the number one killer 
infectious disease-affecting adults in developing 
countries. The 1990 World Health Organization 
(WHO) report on the Global Burden of Disease 
ranked TB as the seventh most morbidity-
causing disease in the world, and expected it to 
continue in the same position up to 20201. 
Worldwide statistics are staggering: in 2001, the 
WHO estimated that 1.86 billion persons were 
infected with tuberculosis. Each year, 8.74 
million develop tuberculosis and nearly 2 
million die. This means that someone 
somewhere contracts TB every four seconds and 
one of them dies every 10 seconds2. WHO 2006 
report on Global Tuberculosis Control published 
on March 24th, World TB Day, once again ranks 
India as the world’s most heavily affected 
country. Based on the huge volume of 
information gathered in India, and drawing on 
our long-standing collaboration with Indian 
colleagues, it was estimated that there were 1.8 
million new TB cases in India in 2004; that is, 
one in five of all cases worldwide. Roughly, 
330,000 people died with TB in 2004 - nearly 
1000 people every day. These figures put India 
some way ahead of the second-ranking country, 
China, which had about 1.3 million new 
episodes of TB in 20043. Around the same time, 
in 1993, WHO declared TB a global emergency 
and devised the directly Observed Treatment - 
Short Course (DOTS) strategy and 
recommended that all countries adopt this 
strategy. The strategy is built on five pillars, viz. 
political commitment and continued funding for 
TB control programmes, diagnosis by sputum 
smear examinations, uninterrupted supply of 
high quality anti-TB drugs, drug intake under  
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direct observation, and accurate recording and 
reporting of all registered cases3. While India’s 
report card for the last 10 year has been 
excellent, the next 10 yr are going to be crucial 
for TB control, not just for India, but for Asia 
and the rest of the world. The change in 
duration of symptoms from two weeks or more 
under NTP to three weeks or more under 
RNTCP was a retrograde and untenable step, 
made without any indigenous research 
support.4  
 
MATERIAL AND METHODS  
A cross sectional analysis of the chest 
symptomatics attending the five selected DMCs 
was carried out in the fourth quarter in the year 
2006 and all Sputum Positive cases of 
Pulmonary TB attending chest OPD formed the 
study sample (n=143). Data was collected with 
the help of pretested, semi-structured proforma. 
Patients currently on TB treatment attending 
health facilities for follow-up were excluded. All 
new adult outpatients with cough >2 weeks 
were referred for sputum examination. A 
sputum specimen was collected on the spot 
from each patient; the patient was then 
instructed to return on the following day for 
examination of an overnight specimen (second 
sputum sample) and to provide a spot specimen 
on the following day (third sputum sample)5. 
Those patients found negative on all the three 
sputum examination were called for a repeat 
sputum examination after completion of full 
course of antibiotics.  
The smears were processed and read by trained 
laboratory technicians. Data thus collected were 
compiled and analysed by appropriate statistical 
technique. 
 
RESULTS AND DISUSSION 
The total attendance of chest symptomatic in the 
o u t p a t i e n t  d e p a r t m e n t  o f  s e l e c t e d  D M C s  w a s  
618 (15.3%) out of total OPD of 4044. Number of 
smear positive cases was 143 (23.1%) and 
number of smear negative cases was 475 
(76.9%). 
The detailed results from successive three 
sputum smears examined for all the sputum 
positive in the fourth quarter of 2006 is shown in 
Table 1. The analysis of the data showed that 
reliance on the first specimen (spot) could detect 
88.1% (126/143) of the sputum positive patients. 
In addition, if the second specimen morning was 
also taken into consideration then 97.9% (140) of 
the patients could be detected. The incremental 
yield of the third specimen (spot) smear was less 
than one % in our study.  
 
Table 1: Distribution of Smear Positives 
among Symptomatics in Successive Specimens 
Variables No.  (%) 
New chest symptomatics  618  
Total sputum positive detected  143 (23.1) 
Positive by all 3 specimens  111 (77.6) 
Positive by 1st specimen(spot)  126 (88.1) 
2nd specimen(morning)  140 (97.9) 
3rd specimen(spot)  128 (89.5) 
Additional positive by   
2nd specimen(morning)  16 (11.2) 
3rd specimen(spot)  01 (0.7) 
 
Table-2 shows the comparison between first spot 
specimen, second early morning specimen and 
third spot specimen in terms of case yield. 
Calculated value of Chi Sq. that is 9.9 and 7.9 are 
greater than the table values of Chi Sq. 6.64, 
hence the efficiency for 1st Vs 2nd sputum smear 
and 2nd Vs 3rd sputum smear is significant at 
P<0.01. 
 
Table 2: Comparison of early morning 
Specimen with Successive Spot Specimens 
Characteristics  Frequency (%)  
Total Smear Positives  143 
Only 1st (Spot) +ve  126 (88.1) 
Only 2nd (Morning) +ve  140 (97.9) 
Only 3rd (Spot) +ve  128 (89.5) 
Comparison 
1st Vs 2nd  Chi Sq. = 9.9, P < 0.01 
2nd Vs 3rd  Chi Sq. = 7.9, P < 0.01 
 
Of the three sputum specimens, the early 
morning specimen gave the best results as 
compared to the other two spot specimens. If 
only the early morning specimen were required 
for testing, then approximately 97.9 % of the 
patients could be detected. This is higher yield 
than the results with the two spot specimens (1st 
& 3rd) and the difference is statistically 
significant (P<0.01) (Table-2). Thus, under 
routine conditions, two sputum smears (one of 
which is early morning) can be recommended in 
place of three smears for screening chest 
symptomatics. The reduction in workload may  
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give more time to an overburdened laboratory 
for improving quality of sputum microscopy. In 
addition, there would be saving in the cost of 
laboratory consumables. It has been estimated 
that each smear examination costs about Rs. 7 in 
LRS Institute laboratory6. The saving at national 
level would be enormous if the cost of health 
infrastructure; technicians’ time and patients' 
lost time are added. However, before a change 
in national programme strategy is considered, 
further studies in different situations in the 
country are needed. 
 
Table 3: Presents Repeat Sputum Microscopic Examination after a course of Antibiotics 
DMCs Smear  -ve 
TB suspects 
Repeat Sputum 
Microscopy 
Repeat Smear 
+ ve 
Repeat Smear 
- ve 
1 229  05  00  05 
2 112  00  00  00 
3 29  01  00  01 
4 58  05  01  04 
5 47  00  00  00 
Total  475 (76.9 %)  11 (2.3 %)  01 (9 %)  10 
 
Table-3 shows that of the total 475 (76.9%) smear 
negative TB suspects, repeat sputum microscopy 
was done on only 11 (2.3%) suspects. However, 
from these 11 repeat sputum microscopy one 
suspect was positive for disease. This shows that 
9% sputum positive cases can be detected after 
repeat sputum microscopy among smear 
negative TB suspects after a course of 
antibiotics. In addition, only 11 out of 475 smear 
negative TB suspects were considered for repeat 
sputum microscopy, which is a very less 
number for justifying the importance of repeat 
sputum microscopy.  
 
CONCLSUSION  
Dependence on the first specimen (spot) and 
third specimen (spot) could detect 88.1 % and 
89.5 % of the sputum positive patients’ 
respectively, while morning specimen could 
detect 97.3 % of the sputum positive patients. 
Comparison of 1st Vs 2nd and 2nd Vs 3rd shows a 
significant difference at P < 0.01. Repeat sputum 
Examination in only 11 patients out of 475 TB 
suspects identified 9% (1/11) smear positive 
cases.  
 
RECOMMENDATION  
The study shows that the diagnostic yield of a 
single sputum specimen examined is insufficient 
under field conditions, especially where the 
sputum positivity is low. However, sputum 
positivity of two or more sputum smears did not 
affect diagnostic yield. Further, of the three 
sputum smears examined (spot, early morning, 
spot), the early morning specimen had the best 
result. It is concluded that under field 
conditions, two sputum smears (one of which is 
early morning) is as effective as three smears for 
screening of chest symptomatics. Reduction in 
the number of smears to two is expected to 
reduce cost (both for patients as well as health 
care provider) without compromising quality. 
However, before changing national programme 
policy, more studies in different situations (rural 
areas, difficult areas, etc.) are recommended. 
Secondly, the repeat sputum microscopy needs 
to be strengthened in diagnostic algorithm in the 
RNTCP procedure.  
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